Publisher · 2 documents · 6 figures

Roche

6 verified figures from 2 publications by Roche, a company. Every figure links to the document and sentence it came from.

Data points

Documents

Indicators

Regions

Publisher type

Company

Documents used

Every publication we have taken a number from, with the date we read it and the link status at that time.

Document	Type	Published	Retrieved	Link	Data points
U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments Licence: See source	Press release	10 Sep 2026	15 Sep 2026	Reachable	2
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States Licence: See source	Press release	20 Aug 2026	15 Sep 2026	Reachable	4

Every measure taken from Roche, with its latest value and trend. Each value opens its record.

Pharmaceutical manufacturing facility capital investment United States · as of 20 Aug 2026 Forecast 750 million USD Roche 1 record

Pharmaceutical corporate employment United States · as of 20 Aug 2026 Estimate 25,000 Roche 1 record

Company countries of operation Global · as of 20 Aug 2026 150 Roche 1 record

Company operating locations United States · as of 20 Aug 2026 24 Roche 1 record

Countries with drug approval Global · as of 10 Sep 2026 90 Roche 1 record

Patients treated with drug Global · as of 10 Sep 2026 10,000 Roche 1 record

6 measures. Each name opens the full series; each value opens the record with its source evidence.

Data on this page is published under CC BY 4.0. Credit Roche as the original publisher; each record page carries its own citation.

Roche. Retrieved from StatOrigin: https://statorigin.org/sources/roche

Last verified 27 September 2026. Link status is rechecked weekly.